Evidence map›Paper›PMID 36394011›Full record

ArticleFrontiers in bioengineering and biotechnology2022

Identification of nanoparticle-mediated siRNA-ASPN as a key gene target in the treatment of keloids.

Yipeng Dong, Chuwei Zhang, Qingrong Zhang, Zihan Li, Yixiao Wang, Jun Yan, Gujie Wu, Ling Qiu, Zhihan Zhu, Bolin Wang and 2 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in bioengineering and biotechnology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. ASPORIN: A root of the matter in tumors and their host environment.Biochimica et biophysica acta. Reviews on cancer · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Yipeng DongDepartment of Burns and Plastic Surgery, Affiliated Hospital of Nantong University, Nantong, China.
Chuwei ZhangDepartment of Burns and Plastic Surgery, Affiliated Hospital of Nantong University, Nantong, China.
Qingrong ZhangDepartment of Burns and Plastic Surgery, Affiliated Hospital of Nantong University, Nantong, China.
Zihan LiDepartment of Burns and Plastic Surgery, Affiliated Hospital of Nantong University, Nantong, China.
Yixiao WangMedical School of Nantong University, Nantong, China.
Jun YanDepartment of Burns and Plastic Surgery, Affiliated Hospital of Nantong University, Nantong, China.
Gujie WuMedical School of Nantong University, Nantong, China.
Ling QiuDepartment of Burns and Plastic Surgery, Affiliated Hospital of Nantong University, Nantong, China.
Zhihan ZhuDepartment of Burns and Plastic Surgery, Affiliated Hospital of Nantong University, Nantong, China.
Bolin WangDepartment of Burns and Plastic Surgery, Affiliated Hospital of Nantong University, Nantong, China.
Haiying GuInstitute of Analytical Chemistry for Life Science, Nantong University, Nantong, China.
Yi ZhangDepartment of Burns and Plastic Surgery, Affiliated Hospital of Nantong University, Nantong, China.
Nantong University · CNAffiliated Hospital of Nantong University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

ASPNasporin genekeloidkeloid fibroblastnanoparticlenude mice allograft

Identifiers

PMID36394011
PMCPMC9649824
OpenAlexW4307707489

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.